- Home
- SLS vs ACH Comparison
SLS vs ACH Comparison
Compare SLS & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.79
Company Overview
Basic Information| Metric | SLS | ACH |
|---|---|---|
| Founded | 2012 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 179.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | ACH |
|---|---|---|
| Price | $3.79 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.00 | $4.00 |
| AVG Volume (30 Days) | ★ 14.1M | 2.1M |
| Earning Date | 11-12-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,768,859,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 132.03 |
| 52 Week Low | $0.85 | $1.84 |
| 52 Week High | $5.18 | $15.54 |
Technical Indicators
Market Signals| Indicator | SLS | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | N/A |
| Support Level | $3.23 | N/A |
| Resistance Level | $4.42 | N/A |
| Average True Range (ATR) | 0.62 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 46.38 | 0.00 |
Price Performance
Historical Comparison SLS
ACH
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.